Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bupleurum + ginkgo is a combination of two herbal ingredients commonly used in traditional medicine and dietary supplements. Bupleurum (from various Bupleurum species, such as Bupleurum falcatum) is traditionally used for its purported analgesic, antipyretic, immunomodulatory, anti-inflammatory, and hepatoprotective effects[2][3][5]. Ginkgo (Ginkgo biloba) is widely known for its use in cognitive support and circulatory health; it has been studied for effects on blood viscosity and platelet aggregation[4]. The mechanism of action for bupleurum involves modulation of immune responses (possibly via saikosaponins), while ginkgo's main actions are attributed to flavonoids and terpenoids that may affect vascular function and platelet activity. There are no robust clinical trials supporting the efficacy or safety of this specific combination. Both herbs have potential interactions with other medications—bupleurum may interact with immunosuppressants or diabetes drugs[5], while ginkgo can increase bleeding risk when combined with anticoagulants or antiplatelet agents[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupleurum + ginkgo.